Surgical Site Infection in Caesarean Section Using Alexis O Compared to Metal Retractors

NCT ID: NCT02685696

Last Updated: 2016-02-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-10-31

Study Completion Date

2016-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objective:

To investigate if the use of the newly designed Alexis O Retractor leads to improved intra-operative and post-operative surgical outcomes in the setting of planned elective Caesarean Sections.

Study Design:

This ethically approved study is designed as a prospective, randomized controlled trial in planned, first time Caesarean Sections with 200 patients randomized to either the Alexis-O Retractor group or the conventional group. Patients with wound healing problems, connective tissue disorders, insulin dependent diabetes, bleeding disorders, previous major abdominal surgery and chorioamnionitis are excluded. Outcomes include surgical site infection, intraoperative parameters such as tissue damage, postoperative analgesia requirements and patient satisfaction scores.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Main Hypothesis:

Does the use of the newly designed Alexis O Retractor lead to improved Surgical Site Infection rates intra-operative and post-operative surgical outcomes in the setting of planned elective first time Caesarean Sections in patients compared to the traditional self-retaining metal retractor?

Secondary Hypotheses:

Does the Alexis O Retractor lead to improved intra-operative and post-operative surgical outcomes in the setting of planned elective Caesarean Sections?

Study Design:

The Study is designed as a prospective, randomized controlled trial with 100 patients randomized to the Alexis O Retractor group and 100 patients to the conventional group.

All patients will be recruited following a thorough discussion about the purpose and methodology of the study and full documented consent will be obtained prior to randomization.

Patients with wound healing problems, connective tissue disorders, diabetes, bleeding disorders, previous abdominal surgery apart from laparoscopy and chorioamnionitis will be excluded.

All surgical operators are thoroughly trained in the use and application of the Alexis O Retractor prior to the start of the study and supported by regular teaching demonstrations. The Obstetric Theatre Team is informed and trained in use and application of the Alexis O Retractor within the Study Design.

Ethical Approval:

Ethical Approval has already been obtained from the Ethics committee at the Charité University Hospital Committee and in keeping with ethical standards.

Statistics:

* Data analysis and statistical comparisons will be performed by the appropriate robust statistical methodology.
* Comparisons to be investigated
* Subjective Assessment of the Ease of Application of Retractor Instrument
* Incision to Delivery Time
* Incision to Skin Suture Time
* Subjective Assessment of Visualized Operative Field
* Subjective Assessment of Freedom of Surgical Movement
* Interference from Descending Bowel or Adnexal Tissue
* Bowel and Bladder Trauma
* Need for Bowel Packing
* Need for Paracolic Cleaning of Blood and Amniotic Fluid
* Need for Uterus Exteriorization Intraoperatively
* Fascial Trauma
* Muscle Trauma
* Muscle Suturing
* Coagulation of the Subcutaneous Tissue
* Subcutaneous Tissue Thickness
* Skin Lacerations
* Trauma to the Baby
* Estimated Blood Loss
* Ease of Retractor Removal
* Analgesia Requirements Post Operative
* Wound Healing Problems on Discharge and at 6 Weeks (Telephone Interview)
* Wound Infections (As defined by Centers for Disease Control)
* Time to Hospital Discharge
* 6-Week Scar Pain Scores (Telephone Interview)
* Patient Satisfaction with Wound Healing (Telephone Interview)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgical Site Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Alexis O Retractor

Group 1 received the Alexis-O-Retractor at thet time of first Caesarean Section

Group Type EXPERIMENTAL

Alexis O Retractor

Intervention Type DEVICE

A newly developed abdominal wall retractor for Caesarean Section is the Alexis O Ring which is formed of 2 rings and a interconnecting plastic polyurethane sheath where the flexible inner ring is placed into the abdomen and where the rigid outer ring is rolled to create tension on the plastic sheath providing 360° abdominal wound retraction with simultaneously a tamponade effect whilst covering the abdominal wound during the Caesarean Section and delivery of the baby.

Metal Retractor

Group 2 received the traditional self retaining metal Retractor at thet time of first Caesarean Section

Group Type ACTIVE_COMPARATOR

Metal Retractor

Intervention Type DEVICE

The traditional self-retaining metal Collins Caesarean Wound Retractor.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Alexis O Retractor

A newly developed abdominal wall retractor for Caesarean Section is the Alexis O Ring which is formed of 2 rings and a interconnecting plastic polyurethane sheath where the flexible inner ring is placed into the abdomen and where the rigid outer ring is rolled to create tension on the plastic sheath providing 360° abdominal wound retraction with simultaneously a tamponade effect whilst covering the abdominal wound during the Caesarean Section and delivery of the baby.

Intervention Type DEVICE

Metal Retractor

The traditional self-retaining metal Collins Caesarean Wound Retractor.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Collins

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women
* Elective Caesarean Section
* First Caesarean Section

Exclusion Criteria

* Diabetes
* Chronic auto immune diseases
* Lupus
* Immune deficiency diseases
* HIV
* known bleeding disorders
* full anti-coagulation therapy
* wound healing problems
* previous Caesarean Section
* major abdominal surgery
* laparotomy
* active phase of labor
* suspected chorioamnionitis
* confirmed chorioamnionitis
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Charite University, Berlin, Germany

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Larry Hinkson

Consultant in Obstetrics

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Larry Hinkson, MBBS,MRCOG

Role: PRINCIPAL_INVESTIGATOR

Charité University Hospital

References

Explore related publications, articles, or registry entries linked to this study.

Klingel ML, Patel SV. A meta-analysis of the effect of inspired oxygen concentration on the incidence of surgical site infection following cesarean section. Int J Obstet Anesth. 2013 Apr;22(2):104-12. doi: 10.1016/j.ijoa.2013.01.001. Epub 2013 Mar 13.

Reference Type BACKGROUND
PMID: 23490472 (View on PubMed)

Horiuchi T, Tanishima H, Tamagawa K, Sakaguchi S, Shono Y, Tsubakihara H, Tabuse K, Kinoshita Y. A wound protector shields incision sites from bacterial invasion. Surg Infect (Larchmt). 2010 Dec;11(6):501-3. doi: 10.1089/sur.2009.072. Epub 2010 Sep 17.

Reference Type BACKGROUND
PMID: 20849290 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AlexisO1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.